Practical Approach to Soft Tissue Pathology

Accurate diagnosis of soft tissue tumors is critical for appropriate therapy.  Over-diagnosis (interpretation of a benign entity as malignant) may lead to aggressive and unnecessary surgical procedures, while under-diagnosis (interpretation of a malignant tumor as benign) may result in higher recurrence rates, metastases and potentially a second more mutilating surgery.  Soft tissue tumors are a large and diverse group of rare neoplasms representing less than 1% of adult solid tumors, and the majority of general surgical pathologists do not encounter these specimens on a regular basis.  This highly respected faculty offers you the opportunity to experience a panorama of challenging soft tissue lesions that you might not otherwise encounter in your practice.  Learn from the best how to diagnose and classify them, what are the genetic and molecular characteristics emerging from soft tissue tumor subtypes, and what you need to become skilled at diagnosing, or at least triaging, these unusual lesions.  If you could not attend the Annual Meeting in San Antonio, or if your experience there excited you to learn more about soft tissue pathology, this course is for you!

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians can earn a maximum of 16 AMA PRA Category 1 Credits™ by participating in the CME activities within the March 31 – April 2, 2017 Interactive Microscopy Course.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 12 SAM credit hours.